Advertisement



More in Pharmacy

Novo Nordisk reimburses its staff who've been prescribed the drugs it develops — including its expensive weight loss drug Wegovy, Bloomberg reported Nov. 15. The drugmaker employs about 21,000 people in Denmark. 

The American Society of Health-System Pharmacists rolled out a national membership organization for pharmacy technicians Nov. 16. 

Pharmacies have long faced "clawback fees" from pharmacy benefit managers, and a federal answer to the issue is causing another problem, KFF Health News reported Nov. 15. 

Drones, robots and automated technologies are increasingly deployed across the healthcare landscape to speed workflows and improve efficiency. For pharmacists, amid a nationwide staffing shortage, tech is allowing them to work at the top of their license and serve more patients.

Three years after Mallinckrodt filed for Chapter 11 bankruptcy, the Dublin-based drugmaker said Nov. 14 it has stabilized its business. 

Denmark-based Novo Nordisk is limiting its supply of insulin products, according to the American Society of Health-System Pharmacists' drug shortage database. 

A year after the FDA found shredded quality documents at an Intas Pharmaceuticals drug manufacturing facility in India, Intas' parent company Accord Healthcare resumed making cisplatin, which has been in dire shortage for months.

The nation's second-largest pharmacy benefit manager, Express Scripts, is leaning into Mark Cuban Cost Plus Drugs' business plan by selling drugs priced by their acquisition cost, pharmacy dispensing and service costs.

Advertisement
Advertisement
Advertisement